Comparing Angiomax to Heparin With Protamine Reversal in Patients OPCAB

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2003
The purpose of this study is to examine the safety and efficacy of Angiomax as an alternative anticoagulant to heparin with protamine reversal in patients undergoing off-pump coronary artery bypass graft surgery.
Epistemonikos ID: e686a864442af08c93abdd79670ce75633d92c92
First added on: May 04, 2024